Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/Ch... by Nungruthai Suntronwong, Sitthichai Kanokudom, Thaksaporn Thatsanathorn, Thanunrat Thongmee, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients by Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan, Jiratchaya Puenpa, Natthinee Sudhinaraset, Chintana Chirathaworn, Yong Poovorawan

Get full text

Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients by Anussara Prayongrat, Patjaya Noppaving, Thitiporn Chobarporn, Natthinee Sudhinaraset, Nattaya Teeyapun, Nussara Pakvisal, Watsamon Jantarabenjakul, Jiratchaya Sophonphan, Chawalit Lertbutsayanukul, Yong Poovorawan

Get full text

High prevalence of circulating DS-1-like human rotavirus A and genotype diversity in children with acute gastroenteritis in Thailand from 2016 to 2019 by Siripat Pasittungkul, Fajar Budi Lestari, Jiratchaya Puenpa, Watchaporn Chuchaona, Nawarat Posuwan, Jira Chansaenroj, John Mauleekoonphairoj, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

Effects of public health interventions on the epidemiological spread during the first wave of the COVID-19 outbreak in Thailand. by Sipat Triukose, Sirin Nitinawarat, Ponlapat Satian, Anupap Somboonsavatdee, Ponlachart Chotikarn, Thunchanok Thammasanya, Nasamon Wanlapakorn, Natthinee Sudhinaraset, Pitakpol Boonyamalik, Bancha Kakhong, Yong Poovorawan

Get full text

SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand... by Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Jiratchaya Puenpa, Sitthichai Kanokudom, Suvichada Assawakosri, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanatorn, Siriporn Songtaisarana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand... by Nungruthai Suntronwong, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Jiratchaya Puenpa, Sitthichai Kanokudom, Suvichada Assawakosri, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanatorn, Siriporn Songtaisarana, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

The impact of COVID-19 and control measures on public health in Thailand, 2020 by Ritthideach Yorsaeng, Nungruthai Suntronwong, Ilada Thongpan, Watchaporn Chuchaona, Fajar Budi Lestari, Siripat Pasittungkul, Jiratchaya Puenpa, Kamolthip Atsawawaranunt, Chollasap Sharma, Natthinee Sudhinaraset, Anek Mungaomklang, Rungrueng Kitphati, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine by Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Ritthideach Yorsaeng, Donchida Srimuan, Thaksaporn Thatsanatorn, Sirapa Klinfueng, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan

Get full text

Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity by Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Harit Phowatthanasathian, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanathorn, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Imm... by Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Lakana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Thanunrat Thongmee, Chompoonut Auphimai, Pornjarim Nilyanimit, Nasamon Wanlapakorn, Natthinee Sudhinaraset, Yong Poovorawan

Get full text

Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection by Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, Thanunrat Thongmee, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Ritthideach Yorsaeng, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Pornjarim Nilyanimit, Donchida Srimuan, Thaksaporn Thatsanathorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5 by Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Suvichada Assawakosri, Ritthideach Yorsaeng, Pornjarim Nilyanimit, Ratchadawan Aeemjinda, Nongkanok Khanarat, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Thanunrat Thongmee, Donchida Srimuan, Thaksaporn Thatsanathorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan

Get full text

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Boost... by Nungruthai Suntronwong, Suvichada Assawakosri, Sitthichai Kanokudom, Ritthideach Yorsaeng, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Jira Chansaenroj, Pornjarim Nilyanimit, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Juthathip Mongkolsapaya, Yong Poovorawan

Get full text

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis by Ritthideach Yorsaeng, Kamolthip Atsawawaranunt, Nungruthai Suntronwong, Sitthichai Kanokudom, Jira Chansaenroj, Suvichada Assawakosri, Pornjarim Nilyanimit, Ratchadawan Aeemjinda, Nongkanok Khanarat, Lakkhana Wongsrisang, Chompoonut Auphimai, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Thanunrat Thongmee, Donchida Srimuan, Thaksaporn Thatsanathorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron by Nungruthai Suntronwong, Ritthideach Yorsaeng, Jiratchaya Puenpa, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Sitthichai Kanokudom, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Suvichada Assawakosri, Pornjarim Nilyanimit, Sirapa Klinfueng, Lakkhana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan

Get full text

Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVa... by Suvichada Assawakosri, Sitthichai Kanokudom, Nungruthai Suntronwong, Jira Chansaenroj, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Donchida Srimuan, Thaksaporn Thatsanathorn, Sirapa Klinfueng, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Juthathip Mongkolsapaya, Sittisak Honsawek, Yong Poovorawan

Get full text

Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccinatio... by Suvichada Assawakosri, Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Donchida Srimuan, Thaksaporn Thatsanatorn, Sirapa Klinfueng, Natthinee Sudhinaraset, Juthathip Mongkolsapaya, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan

Get full text

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens by Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Suvichada Assawakosri, Ritthideach Yorsaeng, Pornjarim Nilyanimit, Ratchadawan Aeemjinda, Nongkanok Khanarat, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Thanunrat Thongmee, Apirat Katanyutanon, Wichai Thanasopon, Jirawan Arayapong, Withak Withaksabut, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan

Get full text

Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023 by Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Lakana Wongsrisang, Thanunrat Thongmee, Ratchadawan Aeemjinda, Nongkanok Khanarat, Donchida Srimuan, Thaksaporn Thatsanathorn, Ritthideach Yorsaeng, Apirat Katanyutanon, Wichai Thanasopon, Wichan Bhunyakitikorn, Chaninan Sonthichai, Piyada Angsuwatcharakorn, Withak Withaksabut, Nasamon Wanlapakorn, Natthinee Sudhinaraset, Yong Poovorawan

Get full text